Glaxo starts testing its swine flu vaccine

(AP) -- Drugmaker GlaxoSmithKline says it has started testing its swine flu vaccine in humans.

Glaxo says it plans to conduct 16 clinical trials of its vaccine in more than 9,000 people in Europe, Canada and the United States. It expects to have early results in September from its first trial in Germany. Those data will be shared with drug regulatory authorities so they can make an early decision whether to license the vaccine.

Both Europe and the U.S. have fast-track approval systems for the , to ensure the vaccine is available as soon as possible - and before complete safety tests are finished.

Two other major drugmakers, Novartis and Sanofi-Aventis, began testing their swine flu vaccines earlier this month.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Explore further

Sanofi Pasteur starts testing swine flu vaccine

Citation: Glaxo starts testing its swine flu vaccine (2009, August 14) retrieved 2 December 2020 from https://medicalxpress.com/news/2009-08-glaxo-swine-flu-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments